The University of Notre Dame will host a three-day conference on interdisciplinary biomedical research March 1 to 3 (Sunday to Tuesday) at the University’s McKenna Hall.
The keynote public lecture will be given March 1 by Anantha Shekhar, director of the Indiana Clinical and Translational Sciences Institute (I-CTSI) and professor of pharmacology and neurobiology at the Indiana University School of Medicine. His lecture, “Clinical and Translational Research Cycle: Complex Biomedical Modeling Approach to Human Diseases,” will begin at 5 p.m. in the McKenna Hall Auditorium.
More than 30 invited speakers from research centers, institutes, medical schools and universities across the nation will come together to discuss recent developments in biomedical modeling and experimentation with the intent of forming collaborations.
Complex biomedical modeling efforts include predictive multi-scale simulations consisting of different sub-models at each scale, scalable parallelism for heterogeneous dynamical simulations, a data-rich environment with experimentally determined model parameters and, finally, distributed multidisciplinary research teams and resources.
On March 2, the conference will include a special session titled “Biomedical Technology and Interaction with Industry,” which will include the following speakers and times:
• 3:15-3:50 p.m., David Brenner, president and chief executive officer, Innovation Park at Notre Dame, “Transforming an Idea into a Marketable Innovation”
• 3:50-4:25 p.m., Gregory Crawford, dean of the College of Science, Notre Dame, “Starting a Biotech Company from a University Invention”
• 4:25-4:50 p.m., Brooke Pyne, director, Indiana Economic Development Corporation, “Understanding Indiana’s SBIR/STTR Initiative”
• 4:50-5:25 p.m., Mayland Chang, assistant director, Walther Cancer Research Center, Notre Dame, “From Bench to Bedside: How to Bring a Therapeutic to Commercialization in an Academic Setting”
• 5:45-6:30 p.m., panel discussion on biomedical technology and connection to industry, Brenner, Crawford, Pyne, Chang and Keith March
Registration is free and open to the public, but registration is required to receive all conference materials and meals. The complete conference schedule and online registration is available at http://www.nd.edu/~icsb/.
The conference is sponsored by the College of Science and the Interdisciplinary Center for the Study of Biocomplexity to encourage interdisciplinary collaboration among clinicians and leading researchers in the fields of biomedicine, biochemistry, bioengineering, computational and mathematical biology and biophysics.
Contact: Mark Alber, Notre Dame Chair in Applied Mathematics, 574-631- 8371, email@example.com